中文
From July 23th to 27th, 2023, the 75th Annual American Association of Clinical Chemistry and Clinical Lab Expo (AACC) was successfully held at the Anaheim Convention Center in Anaheim, California, USA. The exhibition is the world's most internationally influential exposition in the field of clinical testing, has become the main place and communication platform for releasing new products and seeking cooperation in the field of clinical testing. The exhibition has more than 2,500 booths and attracts more than 20,000 international medical professionals from more than 100 countries around the world.
At this event, Igenesis showcased its Fully Automated Closed qPCR System and a variety of supporting reagents in the exhibition, which attracted many visitors to exchange ideas and demonstrated the innovation and technical strength of igenesis's molecular diagnostics POCT products.
Igenesis Fully Automated Closed qPCR System-Galaxy Series
Igenesis Fully Automated Closed qPCR System, coupled with iCassette (PCR-fluorescence method), can achieve the fully enclosed integrated fluorescence PCR in vitro qualitative detection and identification. With only 3 steps, it can fully automated and closed the whole process of nucleic acid extraction, purification and fluorescence PCR amplification, and automatically get results, truly achieving ‘sample in-result out’.
Testing Process
Product Advantages
Intelligent
Automate the whole process of fluorescent PCR,Sample in-Result out,Lower operator requirements;
Integrated
Extraction+Amplification+Detection in one,no additional equipment required;
Fully Enclosed
Eliminate sample cross-contamination, no aerosol risk, and biosafety;
Multiplex qPCR Detection
7 color fluorescent channels for multiplex detection;
Rapid Detection
1~2 hours to get results, shorten turn-around time.
Product Parameters
iCassette - Open Platform
iCassette has an intelligent structural design characteristics, unique open integration capabilities. In addition to the use of Igenesis’s own reagents, it can also be compatible with the third parties. It is more suitable for integrating traditional nucleic acid extraction reagents and fluorescent PCR reagents to form integrated molecular POCT products in an iCassette, which greatly saves the products’ development time and cost. More applications can be available.
Until June 2023, igenesis has obtained CE mark for 19 reagents and instruments,overseas business is distributed globally, such as Italy, Chile, Malaysia, Spain, Denmark, Hong Kong, China and Europe, South America, Southeast Asia and other regions.In the future, igenesis will always adhere to the corporate philosophy of "integrity, excellence, innovation and win-win",which provide safe, fast, convenient and accurate POCT solutions for our customers.Empowering Nucleic Acid Testing and boosting POCT of nucleic acid testing reagents.
This exhibition has ended perfectly, looking forward to seeing you next year!
Post time: Aug-02-2023